Key result
Patients with anxiety disorders had a higher risk of developing medical diseases over 10 years, with the highest risk for cerebrovascular disease.
Why the study?
Does chronic anxiety disorder increase the risk of developing nonpsychiatric medical diseases in a general population?
Cohort
Does chronic anxiety disorder increase the risk of developing nonpsychiatric medical diseases in a general population?
Chronic anxiety disorders are associated with a significantly increased risk of developing subsequent medical morbidities, including cardiovascular and cerebrovascular diseases.
Answers are grounded in this paper and cite their sources.
Anxiety disorders were associated with higher later medical morbidity; leaves open whether screening or intervention improves outcomes.
BACKGROUND: The literature indicates increased rates of some medical conditions in patients with anxiety disorders. We used the Saskatchewan Health databases to examine the development of nonpsychiatric medical diseases in patients with anxiety disorders. This study has a large population base, and the Saskatchewan health plan does not limit the provision of services to this population. METHOD: We observed the annual incidence of specified medical conditions in patients with anxiety disorders and in control subjects over a 10-year period. Subjects in both groups had not been treated for the specified medical conditions before the start of the observation period. RESULTS: The anxiety cohort had a significantly higher relative risk of developing medical diseases compared with the control group. The highest relative risk, indicated by the hazard ratio, was for cerebrovascular disease (hazard ratio 2, 95% CI 1.09-3.65). Hazard ratios were significant for cerebrovascular disease and atherosclerosis as well as for ischemic heart, gastrointestinal, hypertensive, and respiratory diseases. CONCLUSIONS: This study provides additional evidence for an association between anxiety disorder and the later development of medical morbidity.
No takes yet. Share an insight, caveat, or question.
Bowen et al. (2000) conducted a cohort in Anxiety disorders. Anxiety disorders vs. Control subjects was evaluated on Development of specified medical conditions (e.g., cerebrovascular disease) (HR 2, 95% CI 1.09-3.65). Patients with anxiety disorders had a higher risk of developing medical diseases over 10 years, with the highest risk for cerebrovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: